Goal: Lose 30-50 lbs

Goal: Lose 30-50 lbs

NEW: Obalon Swallowable Balloon Capsules

Orbera™ Gastric Balloon

NEW: ReShape Dual  Gastric Balloon

Vagus Nerve Stimulator

Other Novel Procedures

Several exciting new technologies can support weight loss in the 30 to 50 pound range — including the new Obalon swallowable balloon, the Orbera™ gastric balloon, the ReShape™ dual balloon and V-bloc® and more.

At Stony Brook, these are backed by an individualized, comprehensive weight loss plan including the tools and support you need to achieve a healthy new way of living.  Our credentialed, multidisciplinary team offers medical management, advanced nutrition and exercise plans, counseling, behavior modification and group support, in addition to today’s most advanced options in surgical and nonsurgical procedures.


Gastric Balloons

Stony Brook is happy to offer all of the current gastric balloon options.

Each balloon device works by occupying space in your stomach, thereby helping you to feel fuller with less food, and helping you to decrease your portion sizes. The balloon(s) remain in your stomach for 6 months, during which time you particiapte in ongoing nutrition and behavioral support sessions. Once the balloon(s) are removed, these sessions continue for an additional 6 months.

To be eligible for a gastric balloon procedure you must be an adult, and have a BMI of 30- 40. You also must commit to participating in a full 12-month program designed to help you with long-term healthy lifestyle habits.

Attend a FREE EDUCATIONAL SEMINAR on intragastric balloons

Held the second Monday of each month, from 5:00 pm-6:00 pm at Stony Brook University Hosptial.

Contact is at (631) 444-2274 for dates, location, and to register for a balloon seminar.


ObalonNEW: Obalon Swallowable Balloon Capsules

One of the most innovative options in obesity treatment today is a swallowable, gas-filled balloon that requires no anesthesia or surgery, and results in nearly twice the weight loss as diet, exercise, and lifestyle therapy alone. Approved by the FDA in September 2016, this exciting new development is the Obalon balloon system, and Stony Brook researchers lead by Aurora Pryor, MD, played a key role in establishing its safety and efficacy.

How It Works. The Obalon system involves a balloon contained within a capsule that, once it reaches the stomach, is inflated with gas via a microcatheter. The inflated balloon helps patients feel full and eat less. It typically can be placed in less than 10 minutes without the use of sedation or anesthesia. Up to three capsules can be used, all of which are removed after six months. A yearlong, moderate intensity diet and behavior modification program accompanies the balloon therapy. The goal is to form new, healthy habits that help keep the weight off.

Clinical Testing Results. “We found not only that significant weight loss was achieved with the Obalon balloon system but also that this weight loss was maintained at 12 months," said Aurora Pryor, MD, director of the Bariatric and Metabolic Weight Loss Center and co-principal investigator for the nationwide multi-center study. "The system’s combination of lifestyle modification and balloon therapy provides a new, low-risk option for patients struggling with obesity." Dr. Pryor, lead author of the study’s findings, presented the study and results at the national conference, Obestity Week 2016.  

For details on the study, see https://medicine.stonybrookmedicine.edu/surgery/blog/new-balloon-pill-helps-patients-lose-nearly-twice-as-much-weight

Watch the ABC news video about the Obalon trial at Stony Brook (1:54 min). 

LEARN MORE


Orbera Orbera™ Gastric Balloon

Orbera combines a gastric balloon that encourages portion control with a 12-month customized weight loss plan and expert support team.

FDA approved in mid 2015 after 20 years of successful use internationally, the Orbera deflated silicone balloon is placed in the stomach endoscopically — which means no incision, no downtime and minimal risk — and it’s then filled with saline solution. The procedure is done on an outpatient basis in just 20 to 30 minutes using mild sedation.

How It Works. The balloon helps patients eat less by taking up space in the stomach. Losing weight and keeping it off, however, demands lifestyle changes. So the Orbera program also requires a 12-month commitment to diet and exercise supported by our team of bariatric specialists, who are experts in medical management, nutrition and exercise.  Six months after the balloon is placed, it is removed — but the lifestyle coaching continues. Your support team works with you for another half year to retrain your appetite, maintain new eating habits and continue your exercise routine. When the year-long program is over, you’ve established healthy lifestyle choices that help you keep the weight off.

Clinical Testing Results. After six months with the Orbera program, people lost more than three times the weight of those who followed diet and exercise alone. 

LEARN MORE


ReShape  ReShape™ Dual Gastric Balloon

The ReShape procedure is a new FDA approved, non-surgical endoscopic approach to weight loss that is proven to help people achieve a significant weight loss. Most Re-Shape patients keep the weight off or continue to lose, even after the balloons are removed.

How It Works. With ReShape, two balloons filled with saline (salt water) are placed temporarily inside your stomach to help you feel less hungry, so you feel satisfied with smaller portions. The balloons are a weight loss jump-start and are only part of the procedure. You also receive a full year of personalized coaching to support your success and help you make the changes that will encourage a lifetime of healthy living. If you do not want, or do not qualify for surgery, the ReShape procedure may be a good option for you.

Clinical Testing ResultsIn a recent study, patients lost more than twice as much weight with ReShape than with diet and exercise alone. 

LEARN MORE



Other Novel Procedures


vBloc  Vagus Nerve Stimulator: V-Bloc®

An electrical stimulation device is laparoscopically placed on the vagus nerve in the abdomen. The pacemaker-like device blocks the sensation of hunger. There is no hospitalization. To qualify, your BMI should be between 40 and 45, or between 35 and 40 with obesity related co-morbidities. Approximately 25 percent of excess body weight can be lost with this procedure. This novel approach was FDA approved late 2014. 

LEARN MORE

Other Procedures

We are actively involved in clinical trials of other novel devices. Please schedule an appointment with our surgeons to learn more.